Chengda Biology announced that its wholly-owned subsidiary, Chengda Biology (Benxi) Co., Ltd., recently received the Drug Registration Certificate for the lyophilized human rabies vaccine (human diploid cell) issued by the National Medical Products Administration.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Chengda Biotech: Lyophilized Human Rabies Vaccine (Human Diploid Cell) Obtains Drug Registration Certificate
Chengda Biology announced that its wholly-owned subsidiary, Chengda Biology (Benxi) Co., Ltd., recently received the Drug Registration Certificate for the lyophilized human rabies vaccine (human diploid cell) issued by the National Medical Products Administration.